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REVIEW

Fungal Infections From Human and Animal Contact
Dennis J. Baumgardner, MD
Aurora University of Wisconsin Medical Group, Aurora Health Care, Milwaukee, WI; Department of Family Medicine
and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI; Center for Urban
Population Health, Milwaukee, WI

Abstract	Fungal infections in humans resulting from human or animal contact are relatively uncommon, but they
include a significant proportion of dermatophyte infections. Some of the most commonly encountered
diseases of the integument are dermatomycoses. Human or animal contact may be the source of
all types of tinea infections, occasional candidal infections, and some other types of superficial or
deep fungal infections. This narrative review focuses on the epidemiology, clinical features, diagnosis
and treatment of anthropophilic dermatophyte infections primarily found in North America. Other humanacquired and zoonotic fungal infections also are discussed in brief. (J Patient Cent Res Rev. 2017;4:78-89.)
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I

n previous publications we have discussed
fungal infections resulting from exposure to soil,
freshwater, and home and yard environments.1-3 In
this fourth article of the series, we will discuss fungal
infections that may be acquired through contact with
humans or certain animals. While it is true that “with
rare exception, mycoses are not transmissible from
patient to patient,”4 fungi that are “contagious” often
involve spread from normal hosts and include some
of the most commonly known and acquired fungal
infections.5-8 Similarly, a few important infections are
transmitted to humans from animals.5-13 Outbreaks
have occurred involving both scenarios of spread.11-14
This narrative review will focus on the anthropophilic
and zoophilic fungal infections likely to be found
in North America, particularly the main group of
infections labeled dermatophytes. Other contagious
fungal infections acquired from human or animals are
briefly addressed.
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Dermatophyte Infections Acquired Through
Direct and Indirect Human Contact
Dermatophyte infections are those in which the
offending agents rely on degradation of keratin, usually
in dead cells of the outer epidermis (stratum corneum).6-8
These infections can involve areas throughout the
superficial body from scalp and hair shafts to feet
and nails (Table 1).8 In persons with normal immune
systems, dermatophytes generally do not grow beyond
the nonliving stratum corneum.6 One exception to this
is Majocchi’s granuloma, in which the infecting fungi
invade the dermal and subcutaneous tissues, perhaps in
response to minor trauma or irritation at the involved
skin site.15,16
Epidemiology
The etiologic fungi of dermatophyte infections may
be anthropophilic (ie, preferring human hosts and
acquired from other humans), zoophilic (acquired
from animal hosts) or geophilic (acquired from
soil).5-8 Anthrophilic and zoophilic fungi are common
etiologies of dermatomycoses, whereas geophilic fungi
remain rare.
The frequency of dermatophyte infections varies by
geographic area, age, gender and personal activities.6,7
Trichophyton tonsurans may be associated with
Review

Table 1. Common Superficial Dermatophyte Infections
Name

Lay term

Description

Tinea capitis

Ringworm of scalp

Infection of the scalp and hair shafts

Tinea corporis

Ringworm of body

Infection of general areas of the body

Tinea barbae

Ringworm of beard

Infection of the skin in parts of the beard and mustache areas

Tinea faciei

Ringworm of face

Infection of the face exclusive of beard and mustache areas

Tinea manuum

Ringworm of hand

Infection of the hands

Tinea cruris

Jock itch

Infection of the groin

Tinea pedis
Tinea unguium

Athlete’s foot
Nail fungus

Infection of the foot
Infection of the nail, a subset of onychomycosis

crowded living conditions and economic deprivation.12
Microsporum canis (predominantly acquired from
cats and dogs) remains a cause of tinea capitis in the
United States, including Puerto Rico.12 A general
predominance of dermatophyte infections in males
may be due to inhibition of the fungi in women by
progesterone,7 but the particular infecting agent also
may affect gender distribution.12,17 The etiologic fungi
of tinea capitis (scalp ringworm) have shifted over
the past several decades in the United States.12 T.
tonsurans has significantly supplanted Microsporum
audouinii; both are anthropophilic fungi.12 Similar
shifts in predominance of etiologic dermatophytes
have occurred in Canada and Europe.12,18
Tinea capitis, the most contagious of dermatophyte
infections,19 may be more often transmitted from
one human to another by sluffed epithelial cells and
hair than by direct contact. Both T. tonsurans and M.
audouinii may be found on clothing and bedding or
furniture, the former on combs and brushes.12 Thus,
fomites are important players in these infections.
Asymptomatic scalp carriage rates may approach 50%
depending on the locale and species distribution.19
Scalp carriage predominately involves anthropophilic
dermatophytes, is highest among early-school-age
children and has variable gender ratios.19 The relative
risk of spread from asymptomatic scalp carriers versus
those with active ringworm is unclear but likely related
to spore load.19 Tinea capitis infections may be passed
from one generation to another within household
families due to low-grade infections or asymptomatic
carriers.12 Recently, an outbreak of M. audouinii
tinea capitis in elementary schools in Germany was
reportedly related to a family returning from vacation
Review

in Africa.20 The authors stressed the importance of
traveling and migration in the changing epidemiology
of tinea capitis dermatophytes.20
The less contagious tinea corporis, manuum and cruris
tend to be caused by the “cosmopolitan” anthropophilic
dermatophytes Trichophyton rubrum, Trichophyton
mentagrophytes complex (which is sometimes
zoophilic) and Epidermophyton floccosum, as well as
the zoophilic M. canis.7 Spread of these dermatophytes,
predominantly the arthroconidia (ie, spores formed
by breaking up of a hypha, the vegetative filament
of the fungus), is more common within closer knit
communities such as schools, sports teams, prisons
or families. In addition to aforementioned items,
spread may be aided by clothes, towels, bedding or
contaminated furniture/changing rooms, or occur as
the result of direct contact.9,13,21-23
Dermatophytes also have been identified in public
baths and swimming pools,24 and epidemiologic
evidence has suggested an association between sources
such as swimming pools and infections such as tinea
pedis.14 Dermatophyte foot and toenail infections
have been spread in worship spaces and other public
environments (eg, locker rooms, fitness centers) where
persons remove their shoes.6
The importance of contagious sports-related tinea
infections was mostly downplayed by one author as
not a major problem to sports-medicine physicians.22
However, the prevalence of tinea infections (usually
T. rubrum and T. tonsurans in the United States)
in 20% of high school athletes and 7% of college
athletes23 (and up to 60% in college wrestlers6) is not
trivial. Such infections include “tinea gladiatorum,”
www.aurora.org/jpcrr
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which are dermatophyte infections spread by close
athletic contact, like wrestling, and for which
manifestations may be related to clothing, helmets
and areas of superficial trauma.25 While the warm,
moist (conditions conducive to fungus growth and
reproduction) environments of sweaty clothing and
helmets certainly increase the risk of superficial fungal
infections, skin-to-skin contact and shared fomites and
facilities promote person-to-person spread.6,23
Pathophysiology
Dermatophyte fungi depend on keratin and other skin
components for growth.6,8,26 This dependence and their
general inability to grow above 37°C restricts infection
by these organisms primarily to the superficial layers of
the body, exclusive of the mucous membranes.6,8 The
arthroconidium must first adhere to the keratinized skin
surface. Carbohydrate microfibrils on the fungal cell
surface anchor the microorganism to the keratinocytes
and possibly to other arthroconidia.6,26 To invade hair
shafts, dermatophytes create a specialized structure
called a penetrating organ.6 Once anchored, the
arthroconidia germinate and form a web or complex
of hyphae, and invasion of sublayers occurs.6,26
Multiple enzymes, including keratinases, elastases
and other proteases directed against skin components,
are released to invade skin cells or penetrate hair.6,26,27
Essentially, these organisms digest their food (ie,
components of human skin cells) external to their own
fungal cells prior to import and metabolism (a rather
unsavory thought).
Innate peptide and medium-chain fatty acid production
help ward off invading fungi.27 However, several factors
increase the likelihood of successful dermatophyte
infection, including immune status, atopy, diabetes
mellitus (onychomycosis), circulatory disorders, prior
trauma or deformity, occlusive boots or clothing,
occupational factors and age (eg, tinea capitis in
school-age children is likely related to the particular
fatty acid composition in the stratum corneum, elderly
are more susceptible to onychomycosis).6,13 The degree
of inflammation depends on the particular fungus and
the host response.6,12
Clinical Presentations
Tinea Capitis: Tinea capitis presents as patches of
hair loss with sometimes irregular, but generally well-
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demarcated, borders. The lesions may coalesce and
include much of the scalp if left untreated.6,8,28 The
disease is most common in children and uncommon in
adults, and there are four types described in the United
States.6 The seborrheic type, an inflammatory and
hyperkeratotic form, is the most common and includes
erythema, patchy or matted alopecia, pustules, nodules,
crusting and weeping (Figure 1). It often presents with
occipital lymphadenopathy in children.6

Figure 1. Seborrheic tinea capitis. (Photograph courtesy
of RegionalDerm.com and Dr. Gary White.)

Also common is the black dot form (noninflammatory
but scaly), which is usually caused by T. tonsurans and
Trichophyton violaceum (Figure 2). The black dots
(very short hair remnants) are caused by the organisms
sporulating within the hair shaft such that it fractures a
few millimeters from the scalp surface.6,8,27

Figure 2. Black dot tinea capitis. (Photograph courtesy
of RegionalDerm.com and Dr. Gary White.)

Review

The alopecia areata type (smooth alopecia in patches
without inflammation or scaling) is rare.6 Also unusual
is “kerion,” an inflamed, heaped-up, boggy, tender
mass with pustules and associated lymphadenopathy
(Figure 3). Kerion is usually caused by T. tonsurans
and M. canis, is produced by a cell-mediated response
to a tinea capitis, and may cause scarring alopecia.6,8,28

variant of tinea capitis occurring in bearded areas of
the face and neck (Figure 4).6 As with tinea capitis,
there can be varying degrees of inflammation, pustules
or exudates, scaling and crusting, alopecia or hair
breakage near the skin surface.6

Figure 4. Tinea barbae. (Photograph courtesy of
RegionalDerm.com and Dr. Gary White.)

Figure 3. Kerion tinea capitis. (Photograph reprinted
from Bennassar A, Grimalt R. Management of tinea capitis
in childhood. Clin Cosmet Investig Dermatol. 2010;3:8998, with permission from Dove Medical Press Ltd.)

Diagnosis of tinea capitis often may be made by
typical appearance. More definitive diagnosis is made
by microscopy (branching hyphae and spores, the
latter present within shortened hair stubs in the black
dot type) and/or culture.6,8,28 Examination with Wood’s
lamp will reveal green fluorescence in the nowunusual occurrence of infection by M. canis. Recently,
molecular techniques such as polymerase chain reaction
(PCR) have been used for dermatophyte identification
in some laboratories.27 The differential diagnosis
depends somewhat on the type of tinea capitis. It may
include seborrheic or atopic dermatitis (usually more
diffuse than tinea capitis), psoriasis, discoid lupus
erythematosus, lichen planus, nonfungal alopecia
areata, traction alopecia and trichotillomania.8,27
Tinea Barbae: Tinea barbae is usually caused by
Trichophyton species and is sometimes considered a
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Tinea barbae should be differentiated from folliculitis
or furunculosis caused by Staphylococcus species and
other bacteria; Candida folliculitis; acne rosacea; acne
vulgaris; pseudofolliculitis due to shaving; perioral,
contact, irritant or Herpes dermatitis; sporotrichosis;
or neoplasia (rare).6,8 Attempts at hair removal may
differentiate dermatophyte tinea barbae from bacterial
infection, as it is painless in the former, painful in the
latter.8
Tinea Faciei: Tinea faciei is dermatophyte infection of
the nonbearded areas of the face.8 Affected patients may
experience burning and itching, which is aggravated
by sunlight exposure. Generally, erythematous circular
lesions are present but are sometimes indistinct
(particularly in dark-skinned individuals). The
lesions may have varying degrees of raised edges or
scaling.8 Differential diagnosis includes dermatitis of
various types, rosacea or discoid lupus erythematosus.
Potassium hydroxide (KOH) preparation microscopy
of scrapings from the active border may be useful in
diagnosis.8
Sometimes subtle tinea faciei is referred to as “tinea
incognito;”8 however, this term also has been generally
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used to describe tinea corporis/cruris/pedis that is
inappropriately treated with oral or high-potency
topical steroids.6 In true tinea incognito the face and
arms are more commonly involved.29 The changed
appearance results in diminished erythema without
a typical scaling red border, irregular outlines, a
folliculitis appearance and/or other combinations of
papules, pustules or nodules.6,29,30 Thus, tinea incognito
can mimic a variety of skin diseases, including those
mentioned for tinea faciei plus psoriasis, impetigo,
pustular dermatosis, erythema migrans, lichen planus
and others.29,30 Diagnosis may be made by KOH
preparation microscopy or histopathology.29,30

confirmation by KOH preparation microscopy or
fungal culture is recommended.9
Tinea Manuum: Tinea manuum is dermatophytosis of
one or both hands (Figure 6).8 It frequently occurs along
with tinea pedis;8 as such, some consider them the same
entity.6 It is most commonly caused by Trichophyton
species.7 Palms are typically hyperkeratotic and very
dry; fingernails may be involved.8 It is frequently
confused with dyshidrotic eczema, less commonly
with contact dermatitis or psoriasis.8

Tinea Corporis: Tinea corporis (ie, body ringworm)
classically presents as well-demarcated, single or
multiple, annular erythematous scaly lesions with
a raised border and central clearing (Figure 5).6,8,9
Varying degrees of itching may be present, and
borders occasionally contain pustules or follicular
papules.8 Nonringworm forms may occur as a series
of vesicles or erythematous plaques.9 Borders may
be indistinct and typical features more variable in the
immunocompromised.6
Figure 6. Tinea manuum.

Figure 5. Tinea corporis. (Photograph courtesy of
RegionalDerm.com and Dr. Gary White.)

Differential diagnosis includes nummular eczema,
contact or other dermatitis, granuloma annulare,
psoriasis, Lyme disease, secondary and tertiary syphilis,
lichen planus, pityriasis rosea and pityriasis rubra
pilaris.8,9 Diagnosis is based on clinical appearance,
although because of the broad differential diagnosis,
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Tinea Cruris: Tinea cruris, or “jock itch,” is generally
caused by Trichophyton species or E. floccosum.7 It
is a dermatophyte infection of the groin (particularly
the proximal medial thighs), perineal and perianal
areas (Figure 7).6,8,9 More common in men, it may
be acute or chronic, with varying degrees of itching
and pain, and may extend to the buttocks or abdomen
(but usually not the scrotum).6,8 Pustules and vesicles
may be present at the (usually raised) active border.
Varying amounts of maceration and excoriation may
be present in addition to erythema and scaling.8 Tinea
cruris often occurs with tinea pedis, and the latter may
be the source of infection.8
Differential diagnosis includes candidal intertrigo
(particularly in women), chafing or mechanical
intertrigo, erythrasma, seborrheic or contact dermatitis,
psoriasis, lichen simplex chronicus, Darier’s disease,
pemphigus vegetans and other entities.6,8,9 Tinea
cruris can occur in infants in the diaper area, where
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Figure 7. Tinea cruris. (Photograph courtesy of
RegionalDerm.com and Dr. Gary White.)

it may be confused with Candida diaper dermatitis.6
Wood’s lamp examination is useful primarily to rule
out erythrasma caused by Corynebacterium, which
produces a coral-colored fluorescence.9 Again, KOH
preparation microscopy and/or fungal culture may be
required for proper diagnosis.
Tinea Pedis: There are three common presentations
of tinea pedis (“athlete’s foot”), a dermatophyte
infection generally caused by Trichophyton species
and occasionally E. floccosum.6-8 Most common is the
interdigital type, which is characterized by itching,
maceration, fissuring and peeling in between the toes
(Figure 8).6,8 It especially involves the fourth and fifth
toes.8

Figure 8. Tinea pedis. In this case, the interdigital
type is present, in addition to spread along the sole of
the foot which, when complete, would represent the
moccasin-type distribution. (Photograph courtesy of
RegionalDerm.com and Dr. Gary White.)

The dry, hyperkeratotic type is usually caused by T.
rubrum and occurs in a moccasin distribution on the
sole, heel and sides of the foot. There are varying
degrees of erythema, hyperkeratosis and scaling (and
sometimes tiny vesicles).6,8
The vesicular type is a chronic (often lifetime) tinea
pedis usually caused by Trichophyton interdigitale
(Figure 9).6 Pruritic vesicles, pustules and sometimes
bullae are typically found on the plantar arch and along
the sides of the feet, including the heel adjacent to the
thicker plantar stratum corneum.6 Wearing of occlusive
shoes may exacerbate the condition.6 Not surprisingly,
those with onychomycosis have occult or overt tinea
pedis; and those with tinea manuum or cruris are apt.31
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Figure 9. Mild case of mixed moccasin distribution tinea
pedis and vescicular type (arrows) (original photograph).
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Differential diagnosis, depending on the type of tinea
pedis, includes erythrasma, other bacterial infections,
nondermatophyte mold causing similar signs and
symptoms, Candida albicans or other yeast infection,
contact dermatitis, eczema and pustular psoriasis.6,8,31
Secondary cellulitis, often from streptococci, may
occur.8 This is the result of fungal-induced skin
breakdown between the toes, which allows pathogenic
bacteria to colonize and invade.8 Secondary bacterial
invasion is particularly likely in the acute ulcerative
type (rare) of tinea pedis.31 This entity is an exacerbation
of interdigital tinea pedis, with erosions and ulcers in
the web spaces.31
Onychomycosis: Onychomycosis most commonly
involves dermatophytes, and this large subset is
termed tinea unguium.6,8 A multicenter survey of
15,000 Canadian patients visiting medical practices
estimated a 6.5% prevalence of onychomycosis, a ratio
of toenail to fingernail disease of 19:1 and proportions
of dermatophyte etiology of 91% for toenails and
71% for fingernails.32 Most dermatophyte species
were anthropophilic, and the significant odds ratio of
reported prior trauma in patients with onychomycosis
compared to those without was 5.4.32
Clinical presentations of onychomycosis are divided
into five clinical types, which may vary according to
etiologic agent and underlying diseases and genetic
make-up.6,33 The most common (90%) is distal and
lateral subungual onychomycosis (Figure 10). It is most
often due to T. rubrum, which progresses proximally
to the cuticle, resulting in thickened, flaky nails with
varying degrees of discoloration.6,33 Other types include
leukonychia (a superficial white infection with patches
or nail pits), proximal subungual onychomycosis
(infection spreads distally from the cuticle), endonyx
subungual (nail plate and bed both infected), and total
dystrophic onychomycosis (entire nail involved in a
combination of the previous types).6,33
Differential diagnosis includes traumatic onycholysis
(which may lead to onychomycosis), psoriasis, lichen
planus, contact or atopic dermatitis, nail dystrophy,
subungual melanoma or squamous carcinoma and
other disorders.6,8 Confirmatory diagnosis is made
by fungal stain (or KOH preparation) and culture of
scrapings of debris following alcohol swabbing and
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Figure 10. Distal and lateral subungual onychomycosis
(original photograph). This photograph was taken several
years after traumatic onycholysis.

nail clipping as described by Gupta et al.33 However,
a recent analysis indicated that empiric treatment of
onychomycosis with terbinafine is more cost-effective
than confirmatory testing with fungal periodic acidSchiff stain or KOH prep.34 The opposite was true for
treatment with 10% topical efinaconazole.34
Majocchi’s Granuloma: Majocchi’s granuloma
occurs when dermatophytes like T. rubrum –– or,
rarely, nondermatophytes such as Aspergillus sp. ––
invade the dermis and subcutaneous tissue, usually
via disrupted hair follicles (Figure 11).6 This entity is
usually precipitated by trauma or shaving, largely on

Figure 11. Majocchi’s granuloma. (Photograph reprinted
from Kurian A, Haber RM. Tinea corporis gladitorium
presenting as Majocchi granuloma. ISRN Dermatol.
2011;2011:767589, with permission from the authors
under the Creative Commons Attribution License.)
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the extremities, occasionally on the scalp or face.6,15,16
It is most common in children and usually presents
as localized area of erythema, perifollicular papules,
small nodules or pustules (with deeper plaques or larger
nodules in the immunocompromised).15,16 Topical
steroids or occlusion may promote this entity.6,15 As
the differential diagnosis is quite broad, skin biopsy is
usually necessary for confirmation.15
Id Reaction: The id reaction is an acute, local or
more generalized, papulovesicular eruption that is
usually remote from the site of dermatophyte infection
(Figure 12).6,35 It occurs not from direct infection by
dermatophytes or other fungal, bacterial, viral or
parasitic infection, but rather from sensitization to
circulating antigens, in this case, fungal.35 The reason
that tinea pedis is the most commonly associated
dermatophyte infection may be due to the fact that
T. mentagrophytes is the most likely cause of acute
dermatophyte foot infections and that this species
induces a greater human response than others.35 The id
reaction should not be mistaken for a drug reaction.6,35

Figure 12. Id reaction, in this case on the arm, in

response to a primary inflammatory condition the leg.
(Photograph courtesy of RegionalDerm.com and
Dr. Gary White.)

Treatment
Common treatment regimens are summarized in Table
2.6,8,15,16,27,35-41 Localized superficial skin dermatophyte
infections may be treated by topical antifungals.6,8,36
Adding topical corticosteroids to topical antifungal
treatment is not suggested by guidelines and does not
alter the rate of mycological cure, but may improve
time to clinical cure due to treatment of inflammation.36
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Tinea capitis, tinea barbae and Majocchi’s granuloma
require oral antifungal therapy.6,15,16,38 All treatments
may require dosage and duration adjustments in
immunocompromised individuals.6,16
A number of extracts from medicinal plants are
being investigated as possible additional therapeutic
agents for dermatophyte infections.42 Many have
antidermatophytic activity in vitro, and some
have exhibited synergy with conventional azole
antifungals.42 Positive results were seen in mostly
small trials using eucalyptus oil, tea tree (Melaleuca
alternifolia) oil, Ageratina pichinchensis extract, a
flavonoid extract and other agents.42-44 Regarding the
former, eucalyptus containing Vicks® VapoRubTM
(Proctor & Gamble Co., Cincinnati, OH) was applied
to onychomycotic toenails for 48 weeks in an
uncontrolled trial.45 Mycologic and clinical cure was
seen in 5 of 15 subjects, and 10 had partial clearance
with a variety of fungal etiologies.45
Three randomized controlled trials of tea tree oil
alone for integumentary fungal infections have
been reported.44 Satchell et al found a clinical cure
after 4 weeks in 68%–72% with 25%–50% tea
tree oil (placebo response: 39%) and mycological
cure in 55%–64% (placebo response: 31%) of 120
evaluable patients with dermatophyte tinea pedis.46
Moderate to severe dermatitis that resolved with
discontinuation was observed in 4%.46 In a study of
70 subjects, Tong et al found 10% tea tree oil cream
as clinically effective as topical tolnaftate at 4 weeks,
but with mycological cure equivalent to placebo.47
Buck and colleagues compared 100% tea tree oil
to 1% clotrimazole solution in 117 subjects with
onychomycosis.48 After 6 months, mycological cure
was low and equivalent in both groups. Three months
following the course, 56% in the tea tree oil group and
55% of the clotrimazole group had continued clinical
improvement or resolution; local irritation, erythema
or edema occurred in 8% of each group.48
Nondermatophyte Infections Acquired Through
Human Contact
Malassezia species are commensal fungi of the
skin and are discovered in most humans when they
metabolize fatty acid secreted by skin cells.7 They
are the etiologic agents of tinea versicolor, which is
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Table 2. Treatment of Dermatophyte Infections of the Integument
Disease

Treatment

Localized
superficial; skin
dermatophyte;
tinea infections
(eg, corporis,
faciei, manuum,
cruris, pedis)

Topical application of antifungal creams:
azoles (eg, clotrimazole, miconazole),
terbinafine, ciclopirox, tolnaftate, others.
Use for 1–4 weeks.6,8,36

Extensive or
recalcitrant
superficial skin
infections

Tinea capitis

Most common
side effects*

Comments

Local reactions and
irritations, pruritis,
erythema, contact
dermatitis, skin
discoloration (may
vary with product)

Area of most active fungal growth may
be on normal-appearing skin near welldemarcated lesions; topical application
should include 1-inch margin beyond
the border of the lesion.

Itraconazole (200 mg PO daily for 1 week or
100 mg daily for 2 weeks; not FDA-indicated
for this use), terbinafine (250 mg PO daily for
2–4 weeks; not FDA-indicated for this use),
or fluconazole (150 mg PO weekly for 2–4
weeks).6

Edema, pruritis, rash,
GI/upper respiratory
symptoms, sinusitis,
elevated liver enzymes,
headache, dizziness;
fever (terbinafine only)

Pediatric treatment is similar, but
systemic medications are weightadjusted (consult current drug
monographs).37

Griseofulvin microsize (125–250 mg PO daily
for children 13.6–22.7 kg and 250–500 mg daily
for those > 22.7 kg; 500 mg daily for adults), or
griseofulvin ultramicrosize in ages ≥ 2 years
(125–187.5 mg PO daily for children 16–27 kg
and 187.5–375 mg daily for those > 27 kg;
375 mg daily for adults). Therapy is typically
6 weeks but can be 12 weeks or longer.38

Nausea, vomiting,
headache

Selenium sulfide (1 or 2.5%) shampoo
or 2% ketoconazole shampoo may be
used for the first 2 weeks to reduce
transmission.37,38

Terbinafine in ages ≥ 4 years (125 mg PO daily
if weight < 25 kg, 187.5 mg daily for 25–35 kg,
and 250 mg daily for those > 35 kg). Treat for
6 weeks.38

As noted above for
terbinafine

For moccasin-type tinea pedis, 40%
urea cream may be useful adjunct.6

Kerion should generally be treated with
griseofulvin.38 Careful removal of crusts
with wet compresses may be helpful.27

Tinea barbae

Griseofulvin microsize (500 mg PO daily) or
As noted above for
ultramicrosize (375 mg daily) until infection clears. griseofulvin

Majocchi’s
granuloma

Terbinafine (250 mg PO daily for 2–6 weeks),
As noted above
itraconazole (200 mg PO twice daily for 1 week
for terbinafine and
for 2 or 3 pulses with 2 weeks between pulses, or griseofulvin
100 mg PO daily for 20–30 days [all for adults]);
or griseofulvin ultramicrosize (15 mg/kg PO
daily for 5–8 weeks for children, or 500 mg twice
daily for 30 days for older children and adults).15,16,37

Onychomycosis

Terbinafine (adult dosages of 250 mg PO daily
for 6 weeks for fingernail infections and 12
weeks for toenail infections) appears to be the
preferred treatment for onychomycosis.6,35,39

As noted above for
terbinafine

Itraconazole (200 mg per day for
12 weeks) also may be used for
toenails, particularly for candidal and
nondermatophyte mold infections.39

Topical alternatives: efinaconazole 10% solution Ingrowing toenail
daily for 48 weeks (adults, toenails).40
(2.2%), dermatitis
(2.1%), vesicles
(1.5%).40

Complete cure rate of 18.5%.40

Ciclopirox olamine 8% lacquer daily for
48 weeks, remove with alcohol every 7 days
(ages ≥ 12 years).

Pruritis, burning
sensation

Complete cure rate of 5.5%–8.5%.36
May have best success with distal
subungual type and when upper nail
surface is filed or is otherwise more
easily penetrated.6,38,39

Tavaborole 5% solution daily for 48 weeks
(adults, toenails).41

Ingrowing toenail
(2.2%), exfoliation
(2.7%), erythema
(1.6%), dermatitis
(1.3%).41

Complete cure rate of 6.5%–9.1%41

Surgical or chemical nail avulsion is an
additional or alternative option in some
cases.39

*Source (unless otherwise noted): Micromedex 2.0 clinical decision support software (Truven Health Analytics Inc., Ann Arbor, MI).
FDA, Food and Drug Administration; GI, gastrointestinal; PO = by mouth.
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more likely to occur in immunocompromised patients
–– including those with human immunodeficiency
virus –– and in those with cortisol excess or
malnutrition.7 These fungi may cause a folliculitis in
the immunocompromised individual and trigger atopic
and seborrheic dermatitis in susceptible individuals.7,49
While most Malassezia infections indeed arise from
endogenous organisms, hospitalized neonates are
colonized at high rates following birth, perhaps in part
from the hands of health care workers.49
C. albicans is a common cause of cutaneous disease
in infants. The yeast may be acquired from the mother
during passage through the birth canal, or later in
infancy from caregivers.7 Infant diaper rash, oral
thrush, vaginitis, intertriginous candidiasis and hand
dermatitis may all be caused by C. albicans and related
yeasts.7 Candida species may be transmitted by casual
or intermittent human contact, including sexual contact,
through nosocomial transmission, and through fomites
and surfaces such as those found in bathrooms.50,51
However, most candidal infections beyond infancy
arise from one’s own endogenous strains.50
Zoonotic Dermatophyte and Nondermatophyte
Fungal Infections
As noted earlier dermatophyte infections are the most
common human fungal infections acquired from
animals, and tinea capitis is the most predominant
of these infections.12 In general, tinea capitis due
to zoophilic, and the rare geophilic, dermatophyte
species tend to cause a more inflammatory disease
than anthropophilic species.10,12,27 The predominant
zoophilic tinea capitis species in North America
is M. canis.7,12 Kerion may be caused by zoophilic
Trichophyton verrucosum or T. mentagrophytes.27
Occasionally, tinea barbae infections are zoonoses and
may be related to farm work with stock animals or
associated fomites.6,8 Domestic animals can transmit
dermatologic fungal infections, especially tinea
corporis and pedis, by direct contact.10,52-54 Zoophilic T.
interdigitale may cause the rare, acute ulcerative type
of tinea pedis described earlier.31
Malassezia pachydermatis fungemia has occurred as
outbreaks in neonatal intensive care units, including
one case in which the employee acquired the strain
from a household dog.49
Review

Sporotrichosis (discussed in detail in previous articles1,2
in this series) may be a zoonotic infection in some
cases.10 There have been epidemiologic associations
of this disease with armadillo hunting, fire-ant
bites and contact with domestic cats infected with
Sporothrix schenckii.10 The latter association has been
controversial regarding whether it represented common
environmental exposure or zoonotic transmission.55
There is molecular evidence favoring transmission of
S. schenckii between cats and humans56 This may be
an emerging route of transmission presently restricted
to certain epidemic locales.57 Rarely, Cryptococcus
(systemic and cutaneous) may be acquired by direct
transmission from birds.53,58
Prevention
General measures for all persons to reduce the risk of
transmission of the aforementioned fungal organisms
include good general hygiene and handwashing,
wearing loose-fitting cotton clothing, keeping feet
clean and dry, laundering socks at 60°C, keeping nails
well-groomed, prompt showering after contact sports
and not sharing personal care items.6,23,31,37 Persons
with tinea capitis should discard or wash all brushes,
combs and headwear.37
Prevention of recurrence of onychomycosis following
clinical cure may be aided by periodic application of
topical antifungal, specific to the nail and/or the plantar
and interdigital foot; footwear decontamination;
treatment of immediate family; and avoidance of
public swimming pools.59 To prevent transmission
of dermatophyte spores from household pets, carpet
cleaning, thorough laundering of clothes and bedding
and changing of heating/cooling system filters are
recommended.52
Conclusions
Human or animal contact may serve as the source of
dermatophyte infections, candidal infections and, rarely,
other types of superficial or deep fungal disease. These
contagious fungal infections include some of the most
commonly encountered diseases of the integument
encountered in primary care practice. Differential
diagnoses of these dermatophyte infections are broad,
and proper recognition and appropriate topical or oral
treatment of these entities is paramount. Specific and
common sense hygiene measures may limit the spread
of anthropophilic and zoonotic fungal infections.
www.aurora.org/jpcrr
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Patient-Friendly Recap
• Fungal infections transmitted through contact
with other infected humans or animals, such as
ringworm, are commonly encountered in primary
care practice.
• The author reviewed the causes, symptoms and
treatment of these contagious infections, with an
emphasis on clinical presentation.
• Prevention measures include good hygiene
and handwashing, keeping feet clean and dry,
showering after contact sports, and not sharing
personal care items.
• Persons with ringworm of the scalp should
discard/wash brushes, combs and headwear.
Conflicts of Interest
None.
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